243 related articles for article (PubMed ID: 25506548)
1. GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance.
Taher J; Baker CL; Cuizon C; Masoudpour H; Zhang R; Farr S; Naples M; Bourdon C; Pausova Z; Adeli K
Mol Metab; 2014 Dec; 3(9):823-33. PubMed ID: 25506548
[TBL] [Abstract][Full Text] [Related]
2. GLP-2 Dysregulates Hepatic Lipoprotein Metabolism, Inducing Fatty Liver and VLDL Overproduction in Male Hamsters and Mice.
Taher J; Baker C; Alvares D; Ijaz L; Hussain M; Adeli K
Endocrinology; 2018 Sep; 159(9):3340-3350. PubMed ID: 30052880
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of sphingolipid synthesis improves dyslipidemia in the diet-induced hamster model of insulin resistance: evidence for the role of sphingosine and sphinganine in hepatic VLDL-apoB100 overproduction.
Dekker MJ; Baker C; Naples M; Samsoondar J; Zhang R; Qiu W; Sacco J; Adeli K
Atherosclerosis; 2013 May; 228(1):98-109. PubMed ID: 23466071
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
5. GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice.
Parlevliet ET; Wang Y; Geerling JJ; Schröder-Van der Elst JP; Picha K; O'Neil K; Stojanovic-Susulic V; Ort T; Havekes LM; Romijn JA; Pijl H; Rensen PC
PLoS One; 2012; 7(11):e49152. PubMed ID: 23133675
[TBL] [Abstract][Full Text] [Related]
6. Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity.
Mangaloglu L; Cheung RC; Van Iderstine SC; Taghibiglou C; Pontrelli L; Adeli K
Metabolism; 2002 Apr; 51(4):409-18. PubMed ID: 11912545
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model.
Taghibiglou C; Carpentier A; Van Iderstine SC; Chen B; Rudy D; Aiton A; Lewis GF; Adeli K
J Biol Chem; 2000 Mar; 275(12):8416-25. PubMed ID: 10722675
[TBL] [Abstract][Full Text] [Related]
8. GLP-1 attenuates intestinal fat absorption and chylomicron production via vagal afferent nerves originating in the portal vein.
Hoffman S; Alvares D; Adeli K
Mol Metab; 2022 Nov; 65():101590. PubMed ID: 36067913
[TBL] [Abstract][Full Text] [Related]
9. Central Nervous System Regulation of Intestinal Lipoprotein Metabolism by Glucagon-Like Peptide-1 via a Brain-Gut Axis.
Farr S; Baker C; Naples M; Taher J; Iqbal J; Hussain M; Adeli K
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1092-100. PubMed ID: 25675997
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
11. Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction.
Haidari M; Leung N; Mahbub F; Uffelman KD; Kohen-Avramoglu R; Lewis GF; Adeli K
J Biol Chem; 2002 Aug; 277(35):31646-55. PubMed ID: 12070142
[TBL] [Abstract][Full Text] [Related]
12. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
13. Effect of GLP-1 based therapies on diabetic dyslipidemia.
Patel VJ; Joharapurkar AA; Shah GB; Jain MR
Curr Diabetes Rev; 2014; 10(4):238-50. PubMed ID: 24998439
[TBL] [Abstract][Full Text] [Related]
14. Central GLP-1 receptor activation improves cholesterol metabolism partially independent of its effect on food intake.
Patel V; Joharapurkar AA; Kshirsagar SG; Patel KN; Bahekar R; Shah G; Jain MR
Can J Physiol Pharmacol; 2016 Feb; 94(2):161-167. PubMed ID: 26629909
[TBL] [Abstract][Full Text] [Related]
15. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
16. Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice.
Kooijman S; Wang Y; Parlevliet ET; Boon MR; Edelschaap D; Snaterse G; Pijl H; Romijn JA; Rensen PC
Diabetologia; 2015 Nov; 58(11):2637-46. PubMed ID: 26254578
[TBL] [Abstract][Full Text] [Related]
17. The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice.
Hsieh J; Longuet C; Baker CL; Qin B; Federico LM; Drucker DJ; Adeli K
Diabetologia; 2010 Mar; 53(3):552-61. PubMed ID: 19957161
[TBL] [Abstract][Full Text] [Related]
18. Multiple factors and pathways involved in hepatic very low density lipoprotein-apoB100 overproduction in Otsuka Long-Evans Tokushima Fatty rats.
Qin B; Anderson RA; Kuzuya T; Kitaura Y; Shimomura Y
Atherosclerosis; 2012 Jun; 222(2):409-16. PubMed ID: 22546076
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
20. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
Parlevliet ET; de Leeuw van Weenen JE; Romijn JA; Pijl H
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
